MarketCap
Facebook
X
Telegram
ClearPoint Neuro ROA Ratio | CLPT
Annual ROA Ratio ClearPoint Neuro
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -26.13 | -48.26 | -51.78 | -29.62 | -21.97 | -22.98 | -46.45 | -78.45 | -51.57 | -109.04 | -83.63 | -33.8 | -90.01 | -105.87 | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -21.97 | -109.04 | -57.11 |
Quarterly ROA Ratio ClearPoint Neuro
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -37.88 | -41.02 | -37.24 | -47.05 | -52.83 | -55.44 | -54.54 | -42.23 | -39.32 | -37.91 | -44.33 | -47.76 | -44.84 | -40.43 | -32.77 | -28.02 | -26.44 | -25.67 | -23.7 | -20.71 | -19.75 | -20.74 | -22.78 | -28.08 | -36.52 | -38.11 | -42.58 | -49.88 | -51.58 | -59.65 | -64.16 | -61.44 | -60.92 | -53.68 | -49.38 | -62.84 | -70.57 | -89.79 | -105.55 | -103.45 | -92.8 | -68.28 | -79.56 | -91.63 | -93.88 | -146.03 | -125.88 | -62.99 | -70.48 | -47.97 | -41.47 | -73.98 | -34.93 | -38.22 | -131.79 | -210.79 | -502.31 | -739.73 | -708.12 | -622.8 | -274.27 | -274.27 | -74.27 |
Quarterly performance
Select metrics to display
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -19.75 | -739.73 | -102.83 |
ROA Ratio of other stocks in the Medical devices industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Abbott Laboratories
ABT
|
7.52 | $ 110.59 | 0.07 % | $ 193 B |  USA |
 |
EDAP TMS S.A.
EDAP
|
-22.1 | - | - | $ 162 M |  France |
 |
Align Technology
ALGN
|
6.58 | $ 174.54 | 0.16 % | $ 12.7 B | USA |
 |
TELA Bio
TELA
|
-47.66 | $ 0.83 | -4.37 % | $ 39 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
7.84 | $ 104.0 | -0.68 % | $ 60.8 B | USA |
 |
Avinger
AVGR
|
-133.04 | - | -20.74 % | $ 369 K | USA |
 |
CONMED Corporation
CNMD
|
2.03 | $ 51.21 | -1.42 % | $ 1.59 B | USA |
 |
Medtronic PLC
MDT
|
5.16 | $ 101.59 | -1.17 % | $ 130 B | USA |
 |
MiMedx Group
MDXG
|
14.18 | $ 3.37 | 1.36 % | $ 498 M | USA |
 |
ThermoGenesis Holdings
THMO
|
-168.44 | - | -25.84 % | $ 171 K | USA |
 |
Talis Biomedical Corporation
TLIS
|
-65.5 | - | 3.55 % | $ 7.96 M | USA |
 |
Myomo
MYO
|
-40.38 | $ 1.32 | -5.71 % | $ 55.2 M | USA |
 |
Insulet Corporation
PODD
|
7.75 | $ 148.03 | -1.19 % | $ 10.4 B | USA |
 |
Profound Medical Corp.
PROF
|
-54.95 | $ 7.66 | 4.36 % | $ 232 M |  Canada |
 |
Quanterix Corporation
QTRX
|
-25.6 | $ 3.3 | -2.51 % | $ 141 M | USA |
 |
Viveve Medical
VIVE
|
-85.0 | - | -15.35 % | $ 1.71 M | USA |
 |
Smith & Nephew plc
SNN
|
5.98 | $ 30.96 | -0.29 % | $ 26.8 B |  Britain |
 |
Sensus Healthcare
SRTS
|
-14.55 | $ 3.42 | 7.39 % | $ 55.8 M | USA |
 |
Stryker Corporation
SYK
|
1.77 | $ 324.18 | -0.48 % | $ 124 B | USA |
 |
Tactile Systems Technology
TCMD
|
6.97 | $ 26.61 | 0.08 % | $ 609 M | USA |
 |
TransMedics Group
TMDX
|
17.81 | $ 91.02 | -2.95 % | $ 3.09 B | USA |
 |
SmileDirectClub
SDC
|
-14.47 | - | -53.45 % | $ 9.71 M | USA |
 |
Viemed Healthcare
VMD
|
7.73 | $ 9.04 | 1.01 % | $ 352 M | USA |
 |
Varex Imaging Corporation
VREX
|
-6.35 | $ 18.45 | 0.03 % | $ 764 M | USA |
 |
Acutus Medical
AFIB
|
-33.33 | - | -26.83 % | $ 2.62 M | USA |
 |
Vivos Therapeutics
VVOS
|
-84.17 | $ 0.09 | -8.14 % | $ 925 K | USA |
 |
BIOLASE
BIOL
|
-58.78 | - | -13.19 % | $ 166 K | USA |
 |
SeaSpine Holdings Corporation
SPNE
|
-14.41 | - | 0.28 % | $ 270 M | USA |
 |
Xtant Medical Holdings
XTNT
|
5.28 | $ 0.28 | -0.68 % | $ 39.1 M | USA |
 |
Zimmer Biomet Holdings
ZBH
|
3.05 | $ 107.39 | -0.87 % | $ 21.3 B | USA |
 |
Apollo Endosurgery
APEN
|
-36.14 | - | - | $ 475 M | USA |
 |
NuVasive
NUVA
|
1.82 | - | - | $ 2.07 B | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
-46.26 | $ 0.37 | 59.63 % | $ 24 M |  Israel |
 |
Penumbra
PEN
|
9.73 | $ 321.48 | -0.11 % | $ 12.5 B | USA |
 |
Conformis
CFMS
|
-53.67 | - | - | $ 16.4 M | USA |
 |
ViewRay
VRAY
|
-39.55 | - | 1.54 % | $ 468 M | USA |
 |
Medigus Ltd.
MDGS
|
6.77 | - | 10.28 % | $ 55.5 M | Israel |
 |
Boston Scientific Corporation
BSX
|
6.62 | $ 44.68 | 1.49 % | $ 66.1 B | USA |
 |
Cutera
CUTR
|
-16.53 | - | -10.19 % | $ 1.99 M | USA |
 |
Neovasc
NVCN
|
-37.58 | - | - | $ 111 M | Canada |
 |
Vapotherm
VAPO
|
-74.97 | - | 6.72 % | $ 34 M | USA |
 |
Nevro Corp.
NVRO
|
-20.48 | - | - | $ 217 M | USA |
 |
Venus Concept
VERO
|
-68.93 | - | - | $ 726 K | USA |
 |
Eargo
EAR
|
-119.24 | - | - | $ 10.2 M | USA |
 |
Sientra
SIEN
|
-13.29 | - | -16.59 % | $ 10.3 M | USA |
 |
Silk Road Medical, Inc
SILK
|
-21.01 | - | - | $ 1.07 B | USA |
 |
Surgalign Holdings
SRGA
|
-77.74 | - | -32.98 % | $ 1.68 M | USA |
 |
Cardiovascular Systems
CSII
|
-11.45 | - | 0.15 % | $ 844 M | USA |
 |
ShockWave Medical
SWAV
|
9.4 | - | - | $ 12.3 B | USA |
 |
Inari Medical
NARI
|
-0.24 | - | - | $ 4.23 B | USA |